WO2000066787A3 - Genes et proteines hepatiques pouvant etre regules par l'hormone de croissance, utilisations associees - Google Patents

Genes et proteines hepatiques pouvant etre regules par l'hormone de croissance, utilisations associees Download PDF

Info

Publication number
WO2000066787A3
WO2000066787A3 PCT/US2000/012366 US0012366W WO0066787A3 WO 2000066787 A3 WO2000066787 A3 WO 2000066787A3 US 0012366 W US0012366 W US 0012366W WO 0066787 A3 WO0066787 A3 WO 0066787A3
Authority
WO
WIPO (PCT)
Prior art keywords
regulatable
proteins
growth hormone
liver genes
liver
Prior art date
Application number
PCT/US2000/012366
Other languages
English (en)
Other versions
WO2000066787A2 (fr
Inventor
John Joseph Kopchick
Jean Tiong
Original Assignee
Univ Ohio
John Joseph Kopchick
Jean Tiong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio, John Joseph Kopchick, Jean Tiong filed Critical Univ Ohio
Priority to US09/959,716 priority Critical patent/US6858389B1/en
Priority to CA002370134A priority patent/CA2370134A1/fr
Publication of WO2000066787A2 publication Critical patent/WO2000066787A2/fr
Publication of WO2000066787A3 publication Critical patent/WO2000066787A3/fr
Priority to US11/032,232 priority patent/US7309572B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

On décrit des gènes et des protéines hépatiques pouvant être régulés par l'hormone de croissance. On peut les utiliser en tant que marqueurs de diagnostic pour les maladies du foie.
PCT/US2000/012366 1999-05-05 2000-05-05 Genes et proteines hepatiques pouvant etre regules par l'hormone de croissance, utilisations associees WO2000066787A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US09/959,716 US6858389B1 (en) 1999-05-05 2000-05-05 Growth hormone-regulatable liver genes and proteins, and uses thereof
CA002370134A CA2370134A1 (fr) 1999-05-05 2000-05-05 Genes et proteines hepatiques pouvant etre regules par l'hormone de croissance, utilisations associees
US11/032,232 US7309572B2 (en) 1999-05-05 2005-01-11 Growth hormone-regulatable liver genes and proteins, and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13266399P 1999-05-05 1999-05-05
US60/132,663 1999-05-05

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09959716 A-371-Of-International 2000-05-05
US11/032,232 Continuation US7309572B2 (en) 1999-05-05 2005-01-11 Growth hormone-regulatable liver genes and proteins, and uses thereof

Publications (2)

Publication Number Publication Date
WO2000066787A2 WO2000066787A2 (fr) 2000-11-09
WO2000066787A3 true WO2000066787A3 (fr) 2002-01-31

Family

ID=22455037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/012366 WO2000066787A2 (fr) 1999-05-05 2000-05-05 Genes et proteines hepatiques pouvant etre regules par l'hormone de croissance, utilisations associees

Country Status (2)

Country Link
CA (1) CA2370134A1 (fr)
WO (1) WO2000066787A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2831890B1 (fr) * 2001-10-31 2006-06-23 Agronomique Inst Nat Rech Utilisation du gene de la cbg comme marqueur genetique de l'hypercortisolemie et des pathologies associees
WO2005082398A2 (fr) * 2004-02-26 2005-09-09 Ohio University Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de façon differentielle dans les cellules musculaires

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158973A2 (fr) * 1984-04-12 1985-10-23 The General Hospital Corporation Essai immunométrique multisite

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158973A2 (fr) * 1984-04-12 1985-10-23 The General Hospital Corporation Essai immunométrique multisite

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
ADAN L ET AL: "Diagnostic markers of permanent idiopathic growth hormone deficiency.", JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol. 78, no. 2, 1994, pages 353 - 358, XP000971698, ISSN: 0021-972X *
COSTA CRISTINA ET AL: "Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus.", FASEB JOURNAL, vol. 12, no. 14, November 1998 (1998-11-01), pages 1455 - 1460, XP002161567, ISSN: 0892-6638 *
HERMANSSON MAJLIS ET AL: "Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: Demonstration of reduced expression after elective surgery.", JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol. 82, no. 2, 1997, pages 421 - 428, XP000971696, ISSN: 0021-972X *
KOPCHICK JOHN J ET AL: "Transgenic models of growth hormone action.", ANNUAL REVIEW OF NUTRITION, vol. 19, 1999, 1999 Annual Reviews Inc. P.O. Box 10139, 4139 El Camino Way, Palo Alto, California 94306, USA, pages 437 - 461, XP000971266, ISBN: 0-8243-2819-1 *
LE STUNFF CATHERINE ET AL: "Growth hormone stimulates interferon regulatory factor-1 gene expression in the liver.", ENDOCRINOLOGY, vol. 139, no. 3, March 1998 (1998-03-01), pages 859 - 866, XP000971253, ISSN: 0013-7227 *
LEMMEY A B ET AL: "Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I.", JOURNAL OF ENDOCRINOLOGY, vol. 154, no. 2, 1997, pages 319 - 328, XP000971284, ISSN: 0022-0795 *
MALHOTRA KHUSHBEER ET AL: "Identification of differentially expressed mRNAs in human fetal liver across gestation.", NUCLEIC ACIDS RESEARCH, vol. 27, no. 3, 1 February 1999 (1999-02-01), pages 839 - 847, XP002161562, ISSN: 0305-1048 *
PANDURO A ET AL: "LIVER-SPECIFIC GENE EXPRESSION IN VARIOUS PATHOPHYSIOLOGIC STATES", HEPATOLOGY, vol. 7, no. 1 SUPPL., 1987, pages 10S - 18S, XP000971276, ISSN: 0270-9139 *
SAGGESE G ET AL: "Diagnosis and treatment of growth hormone deficiency in children and adolescents: Towards a consensus: Ten years after the availability of recombinant human growth hormone: (Pisa, Italy;March 1998).", HORMONE RESEARCH (BASEL), vol. 50, no. 6, December 1998 (1998-12-01), pages 320 - 340, XP002161600, ISSN: 0301-0163 *

Also Published As

Publication number Publication date
CA2370134A1 (fr) 2000-11-09
WO2000066787A2 (fr) 2000-11-09

Similar Documents

Publication Publication Date Title
HK1044543A1 (en) Beta-secretase enzyme compositions and methods.
WO2003011115A3 (fr) Agents de contraste multimères ciblés à base de peptides
AU2002336367A1 (en) Adamts13 genes and proteins and variants, and uses thereof
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU6382100A (en) Parasitic helminth diag2 proteins, nucleic acid molecules, and uses thereof
WO2002036145A8 (fr) Kahalalide f
WO2000063247A3 (fr) Agents chimiotactiques et inhibants tires de l'osteopontine et leurs utilisations
WO2004010925A3 (fr) Genes de mammifere impliques dans la suppression des infections virales et des tumeurs
AU2002368056A1 (en) Novel pla2 enzyme, it's antibody, enzyme inhibitor and use and the preparation methods thereof
AU5245900A (en) Novel protein and dna thereof
MX9806041A (es) Proteina purificada sr-p70.
AU1908100A (en) Isothermal nucleic acid amplification methods
WO2001046463A3 (fr) Methodes de preparation et d'utilisation d'etalons internes destines a des dosages par amplification de l'acide nucleique
AU4515699A (en) Tagging of rna amplicons generated by transcription-based amplification
AU6094200A (en) Nor gene compositions and methods for use thereof
WO2000066787A3 (fr) Genes et proteines hepatiques pouvant etre regules par l'hormone de croissance, utilisations associees
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU4008500A (en) Platelet-derived growth factor related gene and protein
WO2001068846A3 (fr) Proteine transactivatrice transcriptionnelle
WO2002014345A3 (fr) Peptides antimicrobiens isoles a partir de mastocytes
WO2000066784A3 (fr) Genes et proteines de tissu adipeux brun pouvant etre regules par l'hormone de croissance et applications de ceux-ci
AU2001259169A1 (en) Cesert genes, proteins, and modulatory compounds
AU5034200A (en) Oxidoreductase proteins
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2370134

Country of ref document: CA

Ref country code: CA

Ref document number: 2370134

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 09959716

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)